These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 653637)

  • 41. Multiple forms of human factor IX in chromatography and isoelectric focusing.
    Suomela H
    Thromb Res; 1975 Jul; 7(1):101-12. PubMed ID: 1154330
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibitor-neutralisation assay and electro-immuno assay of human factor IX (Christmas factor).
    Bertina RM; van der Linden IK
    Clin Chim Acta; 1977 Jun; 77(3):275-86. PubMed ID: 559555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B.
    Liles D; Landen CN; Monroe DM; Lindley CM; Read MS; Roberts HR; Brinkhous KM
    Thromb Haemost; 1997 May; 77(5):944-8. PubMed ID: 9184407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor IX levels in patients with hemophilia B (Christmas disease) following transfusion with concentrates of factor IX or fresh frozen plasma (FFP).
    Zauber NP; Levin J
    Medicine (Baltimore); 1977 May; 56(3):213-24. PubMed ID: 859444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony.
    Herzog RW; Arruda VR; Fisher TH; Read MS; Nichols TC; High KA
    Thromb Haemost; 2000 Aug; 84(2):352-4. PubMed ID: 10959714
    [No Abstract]   [Full Text] [Related]  

  • 46. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orthotopic liver transplantation in canine hemophilia B.
    Webster WP; Mandel SR; Reddick RL; Wagner JL; Penick GD
    Am J Physiol; 1974 Mar; 226(3):496-500. PubMed ID: 4593805
    [No Abstract]   [Full Text] [Related]  

  • 48. Characterization of factor IX defects in hemophilia B patients.
    Thompson AR; Chen SH
    Methods Enzymol; 1993; 222():143-69. PubMed ID: 8412791
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on factor IX (with a contribution to the method of factor IX determination and on the etiology of hemophilia B)].
    EGLI H; SCHNEIDER W
    Thromb Diath Haemorrh; 1962 Jul; 7():523-37. PubMed ID: 13889447
    [No Abstract]   [Full Text] [Related]  

  • 50. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M
    Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract]   [Full Text] [Related]  

  • 52. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

  • 53. An agarose plate method for detecting alloantisera to coagulant factor IX and factor IX antigen.
    Reisner HM; Strand EA; Chung KS; Roberts HR
    Br J Haematol; 1980 Feb; 44(2):313-21. PubMed ID: 7378302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.
    Gralnick HR; Rick ME
    N Engl J Med; 1983 Jun; 308(23):1393-5. PubMed ID: 6405274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New alternative scheme for human blood coagulation.
    Honorato R; Ivanović N; Novoa E
    Thromb Res; 1976 Jun; 8(6):837-41. PubMed ID: 960057
    [No Abstract]   [Full Text] [Related]  

  • 56. A new drug form of blood coagulation factor IX: red blood cell-entrapped factor IX.
    Sinauridze EI; Vuimo TA; Kulikova EV; Shmyrev II; Ataullakhanov FI
    Med Sci Monit; 2010 Oct; 16(10):PI19-26. PubMed ID: 20885362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.
    Nummi V; Jouppila A; Lassila R
    Int J Lab Hematol; 2017 Aug; 39(4):359-368. PubMed ID: 28406575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal factor VIII and IX levels in early pregnancy and their significance in prenatal diagnosis.
    Fortune WA; Cox JR
    Acta Haematol; 1973; 49(5):314-7. PubMed ID: 4198913
    [No Abstract]   [Full Text] [Related]  

  • 59. Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody.
    Goodall AH; Kemble G; O'Brien DP; Rawlings E; Rotblat F; Russell GC; Janossy G; Tuddenham EG
    Blood; 1982 Mar; 59(3):664-70. PubMed ID: 7059674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of the deficient factor in hemophilic patients].
    Peñaloza-Santillán JA; Arias y Arias J; Resano-Pérez F
    Bol Med Hosp Infant Mex; 1975; 32(1):51-9. PubMed ID: 1109289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.